This post is from a suggested group
Advancements in Neuromodulation and Botulinum Toxin Injections Reshaping the Global Cervical Dystonia Market for Personalized Patient Management
The Cervical Dystonia Market, which focuses on the management of spasmodic torticollis—a painful condition characterized by involuntary contractions of neck muscles causing the head to twist or jerk—is driven by the increasing incidence of movement disorders and continuous improvements in therapeutic interventions. The primary and most effective treatment strategy remains the targeted injection of Botulinum Neurotoxin (BoNT), which temporarily weakens the overactive neck muscles, thereby reducing pain and improving head posture and range of motion. The market’s growth is directly tied to the rising awareness and acceptance of BoNT therapy among neurologists and patients, along with the increasing availability of specialized clinics capable of administering these injections, often guided by electromyography (EMG) or ultrasound imaging for enhanced precision. Furthermore, the development of new BoNT serotypes and formulations that offer longer duration of effect…